Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AERI Nasdaq 2834 http://www.aeriepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aerie Pharmaceuticals Inc

Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET - May 25th, 2022 8:30 pm
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease - May 25th, 2022 6:29 pm
Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease - May 24th, 2022 11:30 am
Further weakness as Aerie Pharmaceuticals (NASDAQ:AERI) drops 12% this week, taking three-year losses to 85% - May 7th, 2022 1:28 pm
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y - May 6th, 2022 7:48 pm
Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates - May 5th, 2022 9:55 pm
Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update - May 5th, 2022 8:01 pm
Aerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET - Apr 28th, 2022 8:35 pm
Aerie Pharmaceuticals Announces Presentations at the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, Colorado, May 1-4, 2022 - Apr 26th, 2022 8:05 pm
Aerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022 - Apr 20th, 2022 8:05 pm
Aerie (AERI) Expands Market Presence Despite Stiff Competition - Apr 11th, 2022 6:54 pm
Aerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET - Apr 6th, 2022 8:30 pm
Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer - Mar 18th, 2022 11:00 am
Top Pharmaceutical Stocks for Q2 2022 - Mar 17th, 2022 2:45 pm
Aerie (AERI) Q4 Earnings Beat Estimates, Revenues Up Y/Y - Feb 25th, 2022 3:14 pm
Aerie Pharmaceuticals (AERI) Tops Q4 Earnings and Revenue Estimates - Feb 24th, 2022 11:00 pm
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update - Feb 24th, 2022 9:01 pm
Aerie Pharmaceuticals Appoints Gary Sternberg, M.D., M.B.A. as Chief Medical Officer - Feb 24th, 2022 11:30 am
Drug/Biotech Stocks' Q4 Earnings on Feb 24: MRNA, EBS & More - Feb 23rd, 2022 4:44 pm
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET - Feb 17th, 2022 9:45 pm